Ajooni Biotech Limited — Others, 05-02-2025: Appointment

Ajooni Biotech Limited has announced a board meeting regarding the regularization of Mr. Ishtneet Bhatia as an Independent Director for a term of five years, effective January 3, 2025. This appointment, approved during the Extra Ordinary General Meeting, strengthens the company's governance framework. The impact on operations should be positive, as it brings in independent oversight, which can enhance decision-making and shareholder confidence. Investors may view this move favorably, reflecting a commitment to transparency and effective governance, suggesting a positive outlook for the company’s strategic direction.